Fisher & Paykel Healthcare Corporation Limited

ASX:FPH ISIN:NZFAPE0001S2

The company designs, manufactures and markets heated humidification products and systems for use in respiratory care and the treatment of obstructive apnea. Its products and systems are sold in over 90 countries worldwide. 
 
     

查看其它语言版本

新闻

11月19日澳洲股市:市场在寻找新的方向

🕔11/19/2009 1:00:20 PM 18268

在一份令人失望的报告显示美国10月份的住房开工数下降了10.6%、批准数下降了4.0%之后,昨晚华尔街结束了连日的上涨,收市下跌。这次下挫显示房地产行业仍承受着压力。

阅读全文
###

72,102 公司背景浏览

  • 本页浏览人次: (过去7日: 21) (过去30日: 92) (自发布以来: 10898) 

公司详细信息

    传真
  • +64 9 574 0158 
  • 主要部门
  • 医疗-制药 
  • 支柱产业
  • 保健 
  • 主页
  • www.fphcare.co.nz

更多新闻纪录

  • 2025/03/12: FPH launches F&P Nova Nasal mask in NZ and AU*
  • 2025/03/11: Ongoing Disclosure Notices - Employee Share Purchase Plan*
  • 2025/03/06: FPH enters into construction contract for fifth NZ building*
  • 2025/03/04: Ceasing to be a substantial holder*
  • 2025/02/28: Ceasing to be a substantial holder*
  • 2025/02/21: Ongoing Disclosure Notice - Ordinary Shares*
  • 2025/02/17: Change in substantial holding*
  • 2025/02/04: Notification of cessation of securities - FPH*
  • 2025/02/03: Costs forecast to increase under new US tariff regime*
  • 2025/01/06: Application for quotation of securities - FPH*
*refer to company website